VOYA Investment Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.3K | Buy |
19,435
+4,455
| +30% | +$13.2K | ﹤0.01% | 2452 |
|
|
2026
Q1 | $46K | Sell |
14,980
-655
| -4% | -$2.84K | ﹤0.01% | 2284 |
|
|
2025
Q4 | $55.7K | Hold |
15,635
| – | – | ﹤0.01% | 2332 |
|
|
2025
Q3 | $139K | Sell |
15,635
-7,445
| -32% | -$75.5K | ﹤0.01% | 2252 |
|
|
2025
Q2 | $213K | Buy |
23,080
+2,303
| +11% | +$19.7K | ﹤0.01% | 2303 |
|
|
2025
Q1 | $178K | Sell |
20,777
-1,998
| -9% | -$18.9K | ﹤0.01% | 2312 |
|
|
2024
Q4 | $245K | Sell |
22,775
-2,305
| -9% | -$17.7K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $142K | Buy |
25,080
+70
| +0.3% | +$404 | ﹤0.01% | 2573 |
|
|
2024
Q2 | $106K | Buy |
25,010
+299
| +1% | +$1.21K | ﹤0.01% | 2655 |
|
|
2024
Q1 | $126K | Sell |
24,711
-3,864
| -14% | -$21.8K | ﹤0.01% | 2582 |
|
|
2023
Q4 | $266K | Buy |
28,575
+643
| +2% | +$4.43K | ﹤0.01% | 2419 |
|
|
2023
Q3 | $183K | Hold |
27,932
| – | – | ﹤0.01% | 2574 |
|
|
2023
Q2 | $227K | Buy |
27,932
+1,549
| +6% | +$13.3K | ﹤0.01% | 2525 |
|
|
2023
Q1 | $226K | Hold |
26,383
| – | – | ﹤0.01% | 2465 |
|
|
2022
Q4 | $244K | Hold |
26,383
| – | – | ﹤0.01% | 2455 |
|
|
2022
Q3 | $272K | Hold |
26,383
| – | – | ﹤0.01% | 2411 |
|
|
2022
Q2 | $264K | Hold |
26,383
| – | – | ﹤0.01% | 2247 |
|
|
2022
Q1 | $325K | Buy |
26,383
+1,300
| +5% | +$16K | ﹤0.01% | 2140 |
|
|
2021
Q4 | $435K | Buy |
25,083
+642
| +3% | +$12.2K | ﹤0.01% | 2102 |
|
|
2021
Q3 | $439K | Hold |
24,441
| – | – | ﹤0.01% | 2122 |
|
|
2021
Q2 | $559K | Sell |
24,441
-1,016
| -4% | -$15K | ﹤0.01% | 2019 |
|
|
2021
Q1 | $381K | Buy |
25,457
+1,172
| +5% | +$12.8K | ﹤0.01% | 2174 |
|
|
2020
Q4 | $131K | Buy |
24,285
+5,716
| +31% | +$30.1K | ﹤0.01% | 2512 |
|
|
2020
Q3 | $84K | Hold |
18,569
| – | – | ﹤0.01% | 2373 |
|
|
2020
Q2 | $91K | Sell |
18,569
-7,594
| -29% | -$28.7K | ﹤0.01% | 2355 |
|
|
2020
Q1 | $82K | Hold |
26,163
| – | – | ﹤0.01% | 2393 |
|
|
2019
Q4 | $68K | Buy |
26,163
+7,629
| +41% | +$20K | ﹤0.01% | 2611 |
|
|
2019
Q3 | $59K | Hold |
18,534
| – | – | ﹤0.01% | 2483 |
|
|
2019
Q2 | $62K | Buy |
+18,534
| New | +$57.6K | ﹤0.01% | 2544 |
|
|
2018
Q2 | – | Sell |
-18,220
| Closed | -$50K | – | 2605 |
|
|
2018
Q1 | $50K | Hold |
18,220
| – | – | ﹤0.01% | 2551 |
|
|
2017
Q4 | $59K | Hold |
18,220
| – | – | ﹤0.01% | 2560 |
|
|
2017
Q3 | $75K | Hold |
18,220
| – | – | ﹤0.01% | 2592 |
|
|
2017
Q2 | $97K | Buy |
18,220
+3,567
| +24% | +$20.6K | ﹤0.01% | 2582 |
|
|
2017
Q1 | $84K | Hold |
14,653
| – | – | ﹤0.01% | 2447 |
|
|
2016
Q4 | $58K | Hold |
14,653
| – | – | ﹤0.01% | 2499 |
|
|
2016
Q3 | $53K | Hold |
14,653
| – | – | ﹤0.01% | 2527 |
|
|
2016
Q2 | $90K | Buy |
+14,653
| New | +$70.8K | ﹤0.01% | 2485 |
|
Other funds holding AVXL
SF
VOYA Investment Management's AVXL Position: Q2 2026 in Review
VOYA Investment Management increased its Anavex Life Sciences (AVXL) stake by 30% in Q2 2026, buying an estimated $13.2K and bringing the position to 19,435 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2452.
VOYA Investment Management first reported a position in AVXL in Q2 2016 and has held it in 37 quarters since. The position peaked at $559K in Q2 2021. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.
- VOYA Investment Management held 19,435 shares of Anavex Life Sciences worth $50.3K as of Q2 2026.
- VOYA Investment Management bought 4,455 Anavex Life Sciences shares in Q2 2026, an estimated $13.2K.
- Anavex Life Sciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2452 holding.
- VOYA Investment Management first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 37 quarters since.
- VOYA Investment Management's Anavex Life Sciences position peaked at $559K in Q2 2021.
- 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.